Clinical Trials Browser

Phase NA × NIH × Dermatologic Complications × Clear all

NCT00498992 2013-09-20

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

Phase NA Unknown

Other solid neoplasm

Dermatologic Complications